The company is sitting on a sizeable cash balance and looks very likely to put it to work with value accretive acquisitions in the near term.
- Forums
- ASX - By Stock
- WES
- Ann: Advance Notice - 2020 Full-year results
Ann: Advance Notice - 2020 Full-year results, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WES (ASX) to my watchlist
|
|||||
Last
$64.50 |
Change
0.060(0.09%) |
Mkt cap ! $72.66B |
Open | High | Low | Value | Volume |
$64.37 | $64.60 | $63.97 | $88.90M | 1.381M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1181 | $64.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$64.50 | 1259 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1181 | 64.490 |
1 | 2210 | 64.480 |
1 | 2031 | 64.460 |
1 | 1808 | 64.450 |
2 | 3210 | 64.430 |
Price($) | Vol. | No. |
---|---|---|
64.500 | 1259 | 2 |
64.520 | 2564 | 2 |
64.530 | 4377 | 1 |
64.540 | 3357 | 3 |
64.550 | 2507 | 3 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
WES (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online